Results

53,808 open tenders

CountryTenderValueClosesDays left

Open and non-selective reference and financing systems (SONS) aimed at encouraging digital equipment for health professionals, establishments, and services

Agence du Numérique en Santé, ParisTED 332366-2026

value not stated1 lot, 16 months

Fri 1 Oct12:00 in Paris

321days

Conclusion of non-exclusive discount agreements pursuant to § 130a, paragraph 8 of the Social Code Book V (Open-House model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 836333-2025

value not stated8 lots

Fri 1 Oct12:00 in Berlin

321days

Conclusion of agreements for the economic supply of contrast media within an Open House model

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 608230-2025

value not stated19 lots

Fri 1 Oct12:00 in Berlin

321days

Drug discount agreements from 01.12.2025 for various active substances within an Open-House procedure

AOK NordWest, HagenTED 679895-2025

value not stated11 lots

Fri 1 Oct17:00 in Berlin

321days

Open house Drug rebate contracts Pegfilgrastim, ATC L03AA13

AOK Bayern - Die Gesundheitskasse, MünchenTED 673779-2025

value not stated1 lot

Sun 3 Oct12:00 in Berlin

323days

Open house for pharmaceutical discount agreements for allergen extracts from grass pollen for sublingual use, trade name Oralair(R), ATC V01AA02

AOK Bayern - Die Gesundheitskasse, MünchenTED 674661-2025

value not stated1 lot

Sun 3 Oct12:00 in Berlin

323days

Open house for pharmaceutical discount agreements for Risankizumab, ATC L04AC18

AOK Bayern - Die Gesundheitskasse, MünchenTED 675355-2025

value not stated1 lot

Sun 3 Oct12:00 in Berlin

323days

Open house on pharmaceutical discount agreements for Natalizumab in the form of concentrate for infusion solution, ATC L04AG03

AOK Bayern - Die Gesundheitskasse, MünchenTED 673381-2025

value not stated1 lot

Sun 3 Oct12:00 in Berlin

323days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Aflibercept (excluding 114, 3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685877-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Tocilizumab (infusion concentrate solution only), ATC L04AC07, for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 683790-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Natalizumab (excl. in the form of IFK), for the period 01.12.25 - 30.11.26 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 684299-2025

€11 lot, 1 year

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Haloperidol (exclusively injection solution), ATC N05AD01 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 683809-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Doravirin, ATC J05AG06 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685244-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Tocilizumab (exclusively pre-filled syringe and pre-filled pen), ATC L04AC07 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 683943-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Sumatriptan (excluding film-coated tablets and tablets), ATC N02CC01 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 684236-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Doravirin + Lamivudin + Tenofovirdisoproxilfumarat, ATC J05AR24 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685134-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Leuprorelin, ATC L02AE02 for the period 01.12.2025 - 30.11.2027

DAK-Gesundheit, HamburgTED 685328-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Abiraterone (exclusively 500 mg 90 units), ATC L02BX03, for the period 01.12.2025 – 30.11.2027

DAK-Gesundheit, HamburgTED 685930-2025

€11 lot, 2 years

Tue 5 Oct12:00 in Berlin

325days

Open framework agreement on pharmaceutical discounts pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) with possibility of accession at any time, so-called approval model 2025-10

Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 549047-2026

value not stated6 lots

Tue 5 Oct23:59 in Berlin

325days

Transport of persons and provision of minibuses or buses in Italian and French territories with departure in Italy

Tunnel Euralpin Lyon Turin SAS, ChambéryTED 630545-2026

value not stated2 lots

Wed 6 Oct12:00 in Rome

326days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.